Cargando…

Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases

Inflammation is the biological response of immune system to protect living organisms from injurious factors. However, excessive and uncontrolled inflammation is implicated in a variety of devastating chronic diseases including atherosclerosis, inflammatory bowel disease (IBD), and rheumatoid arthrit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Zhengyu, Liu, Shiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048351/ https://www.ncbi.nlm.nih.gov/pubmed/33860447 http://dx.doi.org/10.1007/s13346-021-00977-8

Ejemplares similares

Inflammatory responses and inflammation-associated diseases in organs
por: Chen, Linlin, et al.
Publicado: (2017)

Bioresponsive drug delivery systems for the treatment of inflammatory diseases
por: Dou, Yin, et al.
Publicado: (2020)

Predictive Effect of System Inflammation Response Index for Progression of Chronic Kidney Disease in Non-Dialyzing Patient
por: Tang, Leile, et al.
Publicado: (2023)

Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems
por: Placha, Daniela, et al.
Publicado: (2021)

Cannabinoid Delivery Systems for Pain and Inflammation Treatment
por: Bruni, Natascia, et al.
Publicado: (2018)

Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
por: Zhang, Mi, et al.
Publicado: (2022)

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
por: Zhou, Jun, et al.
Publicado: (2022)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
por: Arida, Aikaterini, et al.
Publicado: (2018)

The effects of grounding (earthing) on inflammation, the immune response, wound healing, and prevention and treatment of chronic inflammatory and autoimmune diseases
por: Oschman, James L, et al.
Publicado: (2015)

Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
por: Gao, Caifang, et al.
Publicado: (2019)

Polymeric Carriers for Delivery Systems in the Treatment of Chronic Periodontal Disease
por: Zięba, Magdalena, et al.
Publicado: (2020)

Update on Nanoparticle-Based Drug Delivery System for Anti-inflammatory Treatment
por: Wang, Huailan, et al.
Publicado: (2021)

Systemic inflammatory response syndrome (SIRS) without systemic inflammation
por: Takala, A, et al.
Publicado: (1998)

Intelligent Drug Delivery Microparticles with Visual Stimuli-Responsive Structural Color Changes
por: Sun, Xiaoyan, et al.
Publicado: (2020)

Lactococcus lactis as an Interleukin Delivery System for Prophylaxis and Treatment of Inflammatory and Autoimmune Diseases
por: Campos, Gabriela Munis, et al.
Publicado: (2023)

Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation
por: Weissman, Simcha, et al.
Publicado: (2020)

Corticosteroid delivery using oral mucosa equivalents for the treatment of inflammatory mucosal diseases
por: Said, Zulfahmi, et al.
Publicado: (2021)

Novel drug delivery systems for inflammatory bowel disease
por: Yasmin, Farah, et al.
Publicado: (2022)

Balance impairment and systemic inflammation in chronic obstructive pulmonary disease
por: Tudorache, Emanuela, et al.
Publicado: (2015)

The role of fibromodulin in inflammatory responses and diseases associated with inflammation
por: Zhao, Feng, et al.
Publicado: (2023)

Non Inflammatory Boronate Based Glucose-Responsive Insulin Delivery Systems
por: Dasgupta, Indrani, et al.
Publicado: (2012)

The Role of Thymoquinone in Inflammatory Response in Chronic Diseases
por: Liu, Yan, et al.
Publicado: (2022)

Systemic inflammation in patients of chronic obstructive pulmonary disease with metabolic syndrome
por: Naseem, Sufia, et al.
Publicado: (2019)

Oral Inflammatory Diseases and Systemic Inflammation: Role of the Macrophage
por: Hasturk, Hatice, et al.
Publicado: (2012)

Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment
por: Zhang, Wunan, et al.
Publicado: (2021)

Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases
por: Wang, Junming, et al.
Publicado: (2023)

The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD)
por: Lv, Mei-Yu, et al.
Publicado: (2021)

Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease
por: Ferrer-Picón, Elena, et al.
Publicado: (2020)

Effect of penehyclidine hydrochloride on inflammatory response and oxidative stress in rats with cardiopulmonary bypass related-lung injury
por: He, Man, et al.
Publicado: (2022)

Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation
por: Lugonja, Sofija I., et al.
Publicado: (2023)

Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies
por: Liu, Peng, et al.
Publicado: (2021)

Placental inflammation is not increased in inflammatory bowel disease
por: Taleban, Sasha, et al.
Publicado: (2015)

Chimeric apoptotic bodies functionalized with natural membrane and modular delivery system for inflammation modulation
por: Dou, Geng, et al.
Publicado: (2020)

Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases
por: Woo, Joo Hong, et al.
Publicado: (2015)

Evaluation of the systemic immune inflammation index and the systemic inflammatory response index as new markers for the diagnosis of acute appendicitis in children
por: Siki, Fatma Özcan, et al.
Publicado: (2023)

Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease
por: Fuster, Antonia, et al.
Publicado: (2008)

Chlorogenic acid: a review on its mechanisms of anti-inflammation, disease treatment, and related delivery systems
por: Huang, Jianhuan, et al.
Publicado: (2023)

Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
por: Pauwels, Renske W M, et al.
Publicado: (2021)

Concepts of advanced therapeutic delivery systems for the management of remodeling and inflammation in airway diseases
por: Dhanjal, Daljeet Singh, et al.
Publicado: (2022)

Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery
por: He, Pan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0s8r7v5lusu76bqop1i66m6jp4